ANVO - Trademark Details
Status: 606 - Abandoned - No Statement Of Use Filed
Image for trademark with serial number 88019481
Serial Number
88019481
Word Mark
ANVO
Status
606 - Abandoned - No Statement Of Use Filed
Status Date
2020-11-30
Filing Date
2018-06-28
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2020-03-03
Attorney Name
Law Office Assigned Location Code
N70
Employee Name
MILLER, JUSTIN T
Statements
Goods and Services
Pharmaceutical preparations, namely anticoagulants, for skin care, for treating diabetes; veterinary preparations, namely antioxidants, pain relief medication, for treatment of intestinal bacteria, for treatment of parasites and worms; Sanitary preparations for medical use; pharmaceutical preparations, namely, chemical preparations and substances, gels, creams, lotions, ointments, sprays, powders, and other products for the treatment of dermatological conditions and disorders and other infections of the human skin; personal hygiene products, namely, feminine hygiene pads and tampons, douching preparations for medical use, medicated pre-moistened towelettes and tissues; menstrual system treatment preparations; pharmaceutical preparations in the field of women's health, namely, contraceptives, hormone replacement therapies and pharmaceuticals for treating menopause and its symptoms; dietetic substances for medical use, namely, diet capsules and pills; antiseptics; baby food; materials for tooth fillings and for dental impressions; medical and hygienic disinfectants; bactericides for treating or preventing infections; medical adhesive and menstruation bandages, surgical bandages, adhesive bandages, gauze bandages, bandages for skin wounds; antibiotic ointments, hemorrhoidal ointments, vaginal ointments; calamine lotion; pharmaceutical preparations for treating and preventing insect bites; Dietary and nutritional supplements; Gummy vitamins; Herbal supplements; Liquid vitamin supplements; Medicinal herbal preparations; Mixed vitamin preparations; Multi-vitamin preparations; Natural herbal supplements; Prenatal vitamins; Vitamin A preparations; Vitamin and mineral supplements; Vitamin B preparations; Vitamin C preparations; Vitamin D preparations; multivitamin preparations; Medicated dental rinses; cough syrups; enema preparations; natural health products in the nature of natural dietary supplements, nutritional supplements and homeopathic supplements, containing vitamins, minerals, green foods, antioxidants, herbal extracts, fruit concentrates, proteins, amino acids, plant oils and fiber in powder, capsule, tablet and liquid form; Medicinal and pharmaceutical preparations, namely, analgesics, diuretics, carbonic anhydrase inhibitors in the nature of pharmaceutical preparations used to treat glaucoma, antidepressants, antibiotics, anti-anginal agents, antihypertensives, antiparkinsonian agents in the nature of pharmaceutical agents for treating Parkinson's disease, laxatives, vitamin supplements, calcium supplements, anticonvulsants, anticholinergics, anxiolytics, antianxiety agents, hypoglycemic agents, anti-hystaminics, sedatives, platelet inhibitors, vasodilators; antipsychotics, hypnotics, pharmaceutical preparations used to treat anemia, anti-inflammatory agents, antiemetics, potassium supplements, trichomonacides in the nature of pharmaceutical preparations used to treat trichomoniasis; bronchodilators, urinary antibacterial pharmaceuticals, antiarthritic preparations, glucocorticoids, antiarrhythmic agents, uricosurics, glaucoma therapy preparations, antispasmodic preparations, antihistamines, anti-inflammatories, antifungal preparations and creams for medical use, neuroleptics, pharmaceutical agents used to treat tuberculosis; psychotherapeutics, namely, tranquillizers; antiparkinsonians in the nature of pharmaceutical preparations used to treat Parkinson's disease; antidiabetics preparations; antibacterial pharmaceuticals, spray, cleaners and soap; antiarthritic compositions and preparations; antiarrhythmics; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system; all of the above expressly excluding pesticides
Goods and Services
Promoting the pharmaceutical products of others by advertising and marketing; Marketing services relating to pharmaceutical products and devices, namely, providing pharmacists and other healthcare professionals with marketing information, advice and guidance, access to healthcare specialists, information kiosks, printed and electronic materials, all for use to enhance professional image, building pharmacy and healthcare practices and promoting excellence in pharmacy; Business management of pharmaceutical products related reimbursement programs for others; management of business affairs; commercial administration of the licensing of the goods and services of others; public relations; assistance and consulting relating to marketing and corporate communication; providing office functions; quality management services in the nature of business management services for establishing business quality policy and determining business means for implementing those policies to improve customer satisfaction; business development services; sales promotion services
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2018-07-05
Primary Code
005
International Class
035 - Advertising; business management; business administration; office functions. - Advertising; business management; business administration; office functions.
US Class Codes
100, 101, 102
Class Status Code
6 - Active
Class Status Date
2018-07-05
Primary Code
035
Correspondences
Name
Jeffrey M. Furr
Address
Please log in with your Justia account to see this address.
Trademark Events
Event DateEvent Description
2018-07-02NEW APPLICATION ENTERED IN TRAM
2018-07-05NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2018-10-18ASSIGNED TO EXAMINER
2018-10-25NON-FINAL ACTION WRITTEN
2018-10-25NON-FINAL ACTION E-MAILED
2018-10-25NOTIFICATION OF NON-FINAL ACTION E-MAILED
2019-04-25TEAS RESPONSE TO OFFICE ACTION RECEIVED
2019-04-25CORRESPONDENCE RECEIVED IN LAW OFFICE
2019-04-26TEAS/EMAIL CORRESPONDENCE ENTERED
2019-05-09TEAS VOLUNTARY AMENDMENT RECEIVED
2019-05-09APPLICANT AMENDMENT PRIOR TO EXAMINATION - ENTERED
2019-06-04FINAL REFUSAL WRITTEN
2019-06-04FINAL REFUSAL E-MAILED
2019-06-04NOTIFICATION OF FINAL REFUSAL EMAILED
2019-12-03TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2019-12-03ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2019-12-03TEAS REQUEST FOR RECONSIDERATION RECEIVED
2019-12-03CORRESPONDENCE RECEIVED IN LAW OFFICE
2019-12-04TEAS/EMAIL CORRESPONDENCE ENTERED
2020-01-02ACTION CONTINUING A FINAL - COMPLETED
2020-01-02CONTINUATION OF FINAL REFUSAL E-MAILED
2020-01-02NOTIFICATION OF SUBSEQUENT FINAL EMAILED
2020-01-02TEAS WITHDRAWAL OF ATTORNEY RECEIVED
2020-01-02WITHDRAWAL OF ATTORNEY GRANTED
2020-01-03TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2020-01-03ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2020-01-03TEAS REQUEST FOR RECONSIDERATION RECEIVED
2020-01-03CORRESPONDENCE RECEIVED IN LAW OFFICE
2020-01-03TEAS/EMAIL CORRESPONDENCE ENTERED
2020-01-27APPROVED FOR PUB - PRINCIPAL REGISTER
2020-02-12NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2020-03-03PUBLISHED FOR OPPOSITION
2020-03-03OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2020-04-28NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2020-11-30ABANDONMENT - NO USE STATEMENT FILED
2020-11-30ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED